Laurent Moll Sells 4,698 Shares of Arteris (NASDAQ:AIP) Stock

Key Points

• Laurent Moll, COO of Arteris, sold 4,698 shares at an average price of $8.80, totaling approximately $41,342.40, decreasing his ownership by 1.18% to 394,681 shares.
• Arteris stock rose 1.5% to $8.72 during trading with a 52-week range of $5.46 to $14.29.
• Analysts have mixed ratings for AIP, with three giving a Buy rating and a target price increase from $12.00 to $15.00 by TD Cowen.

Arteris, Inc. (NASDAQ:AIP - Get Free Report) COO Laurent Moll sold 4,698 shares of the business's stock in a transaction on Friday, September 5th. The stock was sold at an average price of $8.80, for a total value of $41,342.40. Following the completion of the transaction, the chief operating officer owned 394,681 shares of the company's stock, valued at $3,473,192.80. This represents a 1.18% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Arteris Stock Up 1.5%

Shares of AIP stock traded up $0.13 during mid-day trading on Tuesday, hitting $8.72. The company's stock had a trading volume of 505,880 shares, compared to its average volume of 561,944. Arteris, Inc. has a 52-week low of $5.46 and a 52-week high of $14.29. The business has a 50-day moving average price of $9.50 and a 200 day moving average price of $8.22.

Arteris (NASDAQ:AIP - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported ($0.11) earnings per share for the quarter, hitting the consensus estimate of ($0.11). Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%.The firm had revenue of $16.50 million during the quarter, compared to analysts' expectations of $16.35 million. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities analysts forecast that Arteris, Inc. will post -0.73 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

AIP has been the subject of several recent analyst reports. Wall Street Zen cut Arteris from a "hold" rating to a "sell" rating in a research note on Sunday. Rosenblatt Securities reiterated a "buy" rating and set a $14.00 price objective on shares of Arteris in a research report on Wednesday, May 21st. Finally, TD Cowen upped their price objective on Arteris from $12.00 to $15.00 and gave the company a "buy" rating in a research report on Wednesday, August 6th. Three research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and an average target price of $15.00.

Institutional Trading of Arteris

A number of hedge funds and other institutional investors have recently bought and sold shares of AIP. Raymond James Financial Inc. purchased a new stake in Arteris in the second quarter worth about $32,000. CWM LLC boosted its stake in shares of Arteris by 4,810.1% in the first quarter. CWM LLC now owns 10,213 shares of the company's stock worth $71,000 after acquiring an additional 10,005 shares during the period. Cambridge Investment Research Advisors Inc. bought a new position in shares of Arteris in the first quarter worth about $95,000. Savant Capital LLC bought a new position in shares of Arteris in the second quarter worth about $97,000. Finally, Kapitalo Investimentos Ltda bought a new position in shares of Arteris in the second quarter worth about $104,000. Hedge funds and other institutional investors own 64.36% of the company's stock.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.